Exhibit 31.2

CERTIFICATIONS
______________

I, Edward J. Weisberger, certify that:

  1.  I  have  reviewed  this  quarterly report on Form  10-Q  of
  IGENE Biotechnology, Inc.;

  2.  Based  on  my  knowledge, this report does not contain  any
  untrue  statement  of  a  material fact  or  omit  to  state  a
  material  fact necessary to make the statements made, in  light
  of  the  circumstances under which such statements  were  made,
  not  misleading  with  respect to the period  covered  by  this
  report;

  3.  Based  on  my  knowledge,  the  financial  statements,  and
  other  financial  information included in this  report,  fairly
  present  in  all  material  respects the  financial  condition,
  results of operations and cash flows of the registrant  as  of,
  and for, the periods presented in this report;

  4.  The  registrant's  other  certifying officer(s) and  I  are
  responsible   for   establishing  and  maintaining   disclosure
  controls and procedures (as defined in Exchange Act Rules  13a-
  15(e)  and  15d-15(e))  and  internal  control  over  financial
  reporting (as defined in Exchange Act Rules 13a-15(f) and  15d-
  15(f) for the registrant and have:

          a.   Designed  such disclosure controls and procedures,
          or caused such disclosure controls and procedures to be
          designed under our supervision, to ensure that material
          information  relating to the registrant, including  its
          consolidated  subsidiaries, is  made  known  to  us  by
          others  within those entities, particularly during  the
          period in which this report is being prepared;

          b.   Designed  such  internal  control  over  financial
          reporting,   or  caused  such  internal  control   over
          financial   reporting   to  be   designed   under   our
          supervision, to provide reasonable assurance  regarding
          the   reliability  of  financial  reporting   and   the
          preparation   of  financial  statements  for   external
          purposes   in   accordance  with   generally   accepted
          accounting principles;

          c.   Evaluated  the  effectiveness of the  registrant's
          disclosure  controls and procedures  and  presented  in
          this report our conclusions about the effectiveness  of
          the  disclosure controls and procedures, as of the  end
          of  the  period  covered by this report based  on  such
          evaluation; and

          d.    Disclosed  in  this  report  any  change  in  the
          registrant's  internal control over financial reporting
          that  occurred  during  the  registrant's  most  recent
          fiscal  quarter (the registrant's fourth fiscal quarter
          in  the  case of an annual report) that has  materially
          affected, or is reasonably likely to materially affect,
          the   registrant's  internal  control  over   financial
          reporting; and

  5.  The  registrant's  other  certifying officer(s) and I  have
  disclosed,  based  on  our most recent evaluation  of  internal
  control  over financial reporting, to the registrant's auditors
  and  the audit committee of the registrant's board of directors
  (or persons performing the equivalent functions):

          a.    All   significant   deficiencies   and   material
          weaknesses  in  the  design or  operation  of  internal
          control  over financial reporting which are  reasonably
          likely to adversely affect the registrant's ability  to
          record,   process,   summarize  and  report   financial
          information; and

          b.   Any  fraud, whether or not material, that involves
          management  or  other employees who have a  significant
          role   in   the  registrant's  internal  control   over
          financial reporting.

Date: November 3, 2008

/S/ EDWARD J. WEISBERGER
___________________________
    EDWARD J. WEISBERGER
    Chief Financial Officer